ATI PN PHARMACOLOGY PROCTORED EXAM V8 2026/2027 - 400 VERIFIED QUESTIONS WITH
MIXED ANSWERS A,B,C,D & RATIONALES | A+ GRADED - NO REPEAT
Course: ATI PN Pharmacology Proctored V8 2026/2027 | 400Q Mixed A/B/C/D: A=98 B=108 C=93 D=101 | 2026/2027 - No
Repeat Edition
9 new versions - 100% unique questions - no repeat from previous PN Pharm file. Original 2026/2027 content, mixed keys.
1. [V8] Benzodiazepine overdose antidote? - Case 1 PN Pharm 2026/2027
A. Naloxone
B. Flumazenil
C. Vitamin K
D. Protamine
Answer: B
Rationale: Flumazenil reverses benzos, risk seizures. - Version 8 2026/2027
2. [V8] Warfarin antidote for bleeding? - Case 2 PN Pharm 2026/2027
A. Vitamin K + 4F-PCC for life-threatening
B. Calcium
C. Protamine
D. Naloxone
Answer: A
Rationale: Vitamin K for warfarin reversal, PCC for severe bleed. - Version 8 2026/2027
3. [V8] Morphine side effects PN monitor? - Case 3 PN Pharm 2026/2027
A. Diarrhea
B. Respiratory depression, sedation, constipation, hypotension, pinpoint pupils
C. No effects
D. Tachycardia only
Answer: B
Rationale: Opioid side effects resp depression. - Version 8 2026/2027
4. [V8] Opioid overdose antidote? - Case 4 PN Pharm 2026/2027
A. Protamine
B. Vitamin K
C. Flumazenil
D. Naloxone - may need repeat due to short half-life
Answer: D
Rationale: Naloxone opioid antagonist, monitor for re-sedation. - Version 8 2026/2027
5. [V8] Ondansetron use? - Case 5 PN Pharm 2026/2027
A. Diarrhea
B. Pain
C. Nausea/vomiting - monitor QT, headache, constipation
D. Fever
Answer: C
Rationale: Zofran antiemetic QT risk. - Version 8 2026/2027
6. [V8] Psyllium teaching? - Case 6 PN Pharm 2026/2027
A. Take with full glass water, may cause bloating, fiber
B. No water
C. Take dry
D. At bedtime only
Answer: A
Rationale: Psyllium needs water. - Version 8 2026/2027
7. [V8] A client taking amlodipine reports ankle swelling. Best response? - Case 7 PN Pharm 2026/2027
A. Take double dose
B. Ankle swelling common with amlodipine - elevate legs, notify provider if worsens, monitor BP
C. Stop drug immediately
D. No action
Answer: B
Rationale: CCB amlodipine causes peripheral edema - elevate legs, monitor. - Version 8 2026/2027
8. [V8] Glargine (Lantus) rule? - Case 8 PN Pharm 2026/2027
A. Give with meals only
B. Do not mix, given at same time daily, no peak - basal insulin
C. IV push
, D. Mix with regular
Answer: B
Rationale: Glargine long-acting no mix, basal. - Version 8 2026/2027
9. [V8] Ibuprofen contraindication? - Case 9 PN Pharm 2026/2027
A. No risk
B. Safe always
C. No contraindication
D. Avoid in ulcer, GI bleed, kidney disease, pregnancy 3rd trimester, bleeding risk
Answer: D
Rationale: NSAID contraindications GI bleed, renal. - Version 8 2026/2027
10. [V8] Iron supplement teaching? - Case 10 PN Pharm 2026/2027
A. Take with OJ/Vit C on empty stomach, dark green stools normal, constipation
B. No teaching
C. Take with milk
D. Take with antacid
Answer: A
Rationale: Iron with Vit C, dark stools normal. - Version 8 2026/2027
11. [V8] Ciprofloxacin teaching? - Case 11 PN Pharm 2026/2027
A. Take at bedtime only
B. Avoid antacids, iron, dairy within 2h, drink fluids, avoid sun - tendon rupture risk
C. No teaching
D. Take with milk
Answer: B
Rationale: Cipro avoid cations, sun, tendon risk. - Version 8 2026/2027
12. [V8] Epinephrine use in anaphylaxis? - Case 12 PN Pharm 2026/2027
A. Anaphylaxis first-line - IM in mid-thigh, bronchodilation, vasoconstriction
B. No use
C. Bradycardia only
D. Hypotension only
Answer: A
Rationale: Epi first in anaphylaxis IM. - Version 8 2026/2027
13. [V8] Phenytoin teaching? - Case 13 PN Pharm 2026/2027
A. Skip doses
B. Good oral hygiene, avoid alcohol, therapeutic 10-20 mcg/mL, gum hyperplasia risk
C. No hygiene
D. Double dose if missed
Answer: B
Rationale: Phenytoin gum hyperplasia, hygiene. - Version 8 2026/2027
14. [V8] Amoxicillin allergic reaction first? - Case 14 PN Pharm 2026/2027
A. Stop drug, notify provider, assess airway - anaphylaxis risk
B. Double dose
C. Give next dose
D. Take with milk
Answer: A
Rationale: Penicillin allergy stop drug, airway assessment. - Version 8 2026/2027
15. [V8] Omeprazole teaching? - Case 15 PN Pharm 2026/2027
A. No risk
B. Double dose
C. Take with food always
D. Take 30 min before breakfast, long-term risk fractures, low Mg2+
Answer: D
Rationale: PPI before breakfast. - Version 8 2026/2027
16. [V8] Ipratropium (Atrovent) teaching? - Case 16 PN Pharm 2026/2027
A. No teaching
B. Avoid if peanut allergy - contains soy lecithin, rinse mouth
C. Take with food
D. No rinse
Answer: B
Rationale: Ipratropium caution peanut/soy allergy, rinse mouth. - Version 8 2026/2027
17. [V8] Levodopa-carbidopa teaching? - Case 17 PN Pharm 2026/2027
, A. Take low protein, avoid high protein reduces absorption, dark sweat/urine normal
B. Take with high protein
C. No teaching
D. Take with milk only
Answer: A
Rationale: Levodopa low protein diet. - Version 8 2026/2027
18. [V8] Loperamide use? - Case 18 PN Pharm 2026/2027
A. Constipation
B. Fever
C. Diarrhea - anti-diarrheal, monitor fluid/electrolytes
D. Pain
Answer: C
Rationale: Loperamide anti-diarrheal. - Version 8 2026/2027
19. [V8] Sertraline interaction? - Case 19 PN Pharm 2026/2027
A. No interactions
B. Safe with MAOI
C. Avoid MAOIs 14 days, risk serotonin syndrome with tramadol/St John's wort
D. No risk
Answer: C
Rationale: SSRI + MAOI serotonin syndrome. - Version 8 2026/2027
20. [V8] LPN cannot do IV push - Case 20 PN Pharm 2026/2027
A. Can do IV push
B. Can do all
C. LPN cannot do IV push meds, initial assessment, teaching, unstable clients
D. Can do assessment
Answer: C
Rationale: LPN scope no IV push, no initial assessment. - Version 8 2026/2027
21. [V8] Insulin lispro onset? - Case 21 PN Pharm 2026/2027
A. 6 hours
B. 15 minutes rapid-acting, peak 1-2h, duration 3-4h
C. 12 hours
D. 2 hours
Answer: B
Rationale: Lispro rapid 15 min onset. - Version 8 2026/2027
22. [V8] Docusate use? - Case 22 PN Pharm 2026/2027
A. Stool softener - softens stool, needs fluids
B. Stimulant
C. Pain
D. Fever
Answer: A
Rationale: Docusate softener. - Version 8 2026/2027
23. [V8] Prednisone long-term side effects? - Case 23 PN Pharm 2026/2027
A. Weight loss
B. Hypoglycemia
C. Weight gain, hyperglycemia, moon face, buffalo hump, osteoporosis, infection risk
D. No effects
Answer: C
Rationale: Steroids cause Cushingoid appearance, hyperglycemia, osteoporosis. - Version 8 2026/2027
24. [V8] Metronidazole teaching? - Case 24 PN Pharm 2026/2027
A. Avoid alcohol during and 48h after - disulfiram reaction nausea/vomiting
B. No teaching
C. Drink alcohol
D. Take with alcohol
Answer: A
Rationale: Flagyl no alcohol disulfiram. - Version 8 2026/2027
25. [V8] Albuterol side effects? - Case 25 PN Pharm 2026/2027
A. Bradycardia
B. Tachycardia, tremor, nervousness - beta2 agonist
C. Weight gain
D. Cough always
, Answer: B
Rationale: Albuterol tachycardia, tremor. - Version 8 2026/2027
26. [V8] Vancomycin infusion reaction red man? - Case 26 PN Pharm 2026/2027
A. Stop forever
B. No action
C. Give fast
D. Infuse slowly over 60-90 min, antihistamine, not allergy
Answer: D
Rationale: Red man from fast infusion - slow infusion. - Version 8 2026/2027
27. [V8] Lisinopril causes dry cough due to? - Case 27 PN Pharm 2026/2027
A. K+ loss
B. Bradykinin accumulation in lungs - ACE inhibitor side effect
C. Na retention
D. Histamine
Answer: B
Rationale: ACE cough from bradykinin. Switch to ARB if intolerable. - Version 8 2026/2027
28. [V8] Hypoglycemia treatment conscious PN? - Case 28 PN Pharm 2026/2027
A. 15g fast carb juice/glucose tabs, recheck 15 min, repeat if <70
B. Water
C. No treatment
D. Give insulin
Answer: A
Rationale: Rule of 15 for hypo. - Version 8 2026/2027
29. [V8] Lithium therapeutic level? - Case 29 PN Pharm 2026/2027
A. 0.1
B. 0.6-1.2 mEq/L, toxicity >1.5 - monitor kidney, thyroid, hydration
C. 10
D. 5.0
Answer: B
Rationale: Lithium narrow therapeutic, monitor. - Version 8 2026/2027
30. [V8] Furosemide expected side effect? - Case 30 PN Pharm 2026/2027
A. Hypokalemia, hypotension, dehydration - monitor K+, I&O;, BP
B. Hyperkalemia
C. No side effects
D. Hypernatremia
Answer: A
Rationale: Loop diuretic wastes K+ - monitor hypokalemia, give K+ rich foods. - Version 8 2026/2027
31. [V8] NPH insulin appearance? - Case 31 PN Pharm 2026/2027
A. No appearance
B. Clear yellow
C. Clear
D. Cloudy - must roll not shake, 30 min to 1h onset, peak 4-12h
Answer: D
Rationale: NPH cloudy intermediate. - Version 8 2026/2027
32. [V8] Haloperidol EPS treatment? - Case 32 PN Pharm 2026/2027
A. No monitor
B. Benztropine/diphenhydramine for acute dystonia, monitor EPS
C. Stop water
D. No treatment
Answer: B
Rationale: Antipsychotic EPS benztropine. - Version 8 2026/2027
33. [V8] Bisacodyl use? - Case 33 PN Pharm 2026/2027
A. Diarrhea
B. Fever
C. Constipation - stimulant laxative
D. Pain
Answer: C
Rationale: Stimulant laxative. - Version 8 2026/2027
34. [V8] Acetaminophen overdose antidote? - Case 34 PN Pharm 2026/2027
A. Naloxone
MIXED ANSWERS A,B,C,D & RATIONALES | A+ GRADED - NO REPEAT
Course: ATI PN Pharmacology Proctored V8 2026/2027 | 400Q Mixed A/B/C/D: A=98 B=108 C=93 D=101 | 2026/2027 - No
Repeat Edition
9 new versions - 100% unique questions - no repeat from previous PN Pharm file. Original 2026/2027 content, mixed keys.
1. [V8] Benzodiazepine overdose antidote? - Case 1 PN Pharm 2026/2027
A. Naloxone
B. Flumazenil
C. Vitamin K
D. Protamine
Answer: B
Rationale: Flumazenil reverses benzos, risk seizures. - Version 8 2026/2027
2. [V8] Warfarin antidote for bleeding? - Case 2 PN Pharm 2026/2027
A. Vitamin K + 4F-PCC for life-threatening
B. Calcium
C. Protamine
D. Naloxone
Answer: A
Rationale: Vitamin K for warfarin reversal, PCC for severe bleed. - Version 8 2026/2027
3. [V8] Morphine side effects PN monitor? - Case 3 PN Pharm 2026/2027
A. Diarrhea
B. Respiratory depression, sedation, constipation, hypotension, pinpoint pupils
C. No effects
D. Tachycardia only
Answer: B
Rationale: Opioid side effects resp depression. - Version 8 2026/2027
4. [V8] Opioid overdose antidote? - Case 4 PN Pharm 2026/2027
A. Protamine
B. Vitamin K
C. Flumazenil
D. Naloxone - may need repeat due to short half-life
Answer: D
Rationale: Naloxone opioid antagonist, monitor for re-sedation. - Version 8 2026/2027
5. [V8] Ondansetron use? - Case 5 PN Pharm 2026/2027
A. Diarrhea
B. Pain
C. Nausea/vomiting - monitor QT, headache, constipation
D. Fever
Answer: C
Rationale: Zofran antiemetic QT risk. - Version 8 2026/2027
6. [V8] Psyllium teaching? - Case 6 PN Pharm 2026/2027
A. Take with full glass water, may cause bloating, fiber
B. No water
C. Take dry
D. At bedtime only
Answer: A
Rationale: Psyllium needs water. - Version 8 2026/2027
7. [V8] A client taking amlodipine reports ankle swelling. Best response? - Case 7 PN Pharm 2026/2027
A. Take double dose
B. Ankle swelling common with amlodipine - elevate legs, notify provider if worsens, monitor BP
C. Stop drug immediately
D. No action
Answer: B
Rationale: CCB amlodipine causes peripheral edema - elevate legs, monitor. - Version 8 2026/2027
8. [V8] Glargine (Lantus) rule? - Case 8 PN Pharm 2026/2027
A. Give with meals only
B. Do not mix, given at same time daily, no peak - basal insulin
C. IV push
, D. Mix with regular
Answer: B
Rationale: Glargine long-acting no mix, basal. - Version 8 2026/2027
9. [V8] Ibuprofen contraindication? - Case 9 PN Pharm 2026/2027
A. No risk
B. Safe always
C. No contraindication
D. Avoid in ulcer, GI bleed, kidney disease, pregnancy 3rd trimester, bleeding risk
Answer: D
Rationale: NSAID contraindications GI bleed, renal. - Version 8 2026/2027
10. [V8] Iron supplement teaching? - Case 10 PN Pharm 2026/2027
A. Take with OJ/Vit C on empty stomach, dark green stools normal, constipation
B. No teaching
C. Take with milk
D. Take with antacid
Answer: A
Rationale: Iron with Vit C, dark stools normal. - Version 8 2026/2027
11. [V8] Ciprofloxacin teaching? - Case 11 PN Pharm 2026/2027
A. Take at bedtime only
B. Avoid antacids, iron, dairy within 2h, drink fluids, avoid sun - tendon rupture risk
C. No teaching
D. Take with milk
Answer: B
Rationale: Cipro avoid cations, sun, tendon risk. - Version 8 2026/2027
12. [V8] Epinephrine use in anaphylaxis? - Case 12 PN Pharm 2026/2027
A. Anaphylaxis first-line - IM in mid-thigh, bronchodilation, vasoconstriction
B. No use
C. Bradycardia only
D. Hypotension only
Answer: A
Rationale: Epi first in anaphylaxis IM. - Version 8 2026/2027
13. [V8] Phenytoin teaching? - Case 13 PN Pharm 2026/2027
A. Skip doses
B. Good oral hygiene, avoid alcohol, therapeutic 10-20 mcg/mL, gum hyperplasia risk
C. No hygiene
D. Double dose if missed
Answer: B
Rationale: Phenytoin gum hyperplasia, hygiene. - Version 8 2026/2027
14. [V8] Amoxicillin allergic reaction first? - Case 14 PN Pharm 2026/2027
A. Stop drug, notify provider, assess airway - anaphylaxis risk
B. Double dose
C. Give next dose
D. Take with milk
Answer: A
Rationale: Penicillin allergy stop drug, airway assessment. - Version 8 2026/2027
15. [V8] Omeprazole teaching? - Case 15 PN Pharm 2026/2027
A. No risk
B. Double dose
C. Take with food always
D. Take 30 min before breakfast, long-term risk fractures, low Mg2+
Answer: D
Rationale: PPI before breakfast. - Version 8 2026/2027
16. [V8] Ipratropium (Atrovent) teaching? - Case 16 PN Pharm 2026/2027
A. No teaching
B. Avoid if peanut allergy - contains soy lecithin, rinse mouth
C. Take with food
D. No rinse
Answer: B
Rationale: Ipratropium caution peanut/soy allergy, rinse mouth. - Version 8 2026/2027
17. [V8] Levodopa-carbidopa teaching? - Case 17 PN Pharm 2026/2027
, A. Take low protein, avoid high protein reduces absorption, dark sweat/urine normal
B. Take with high protein
C. No teaching
D. Take with milk only
Answer: A
Rationale: Levodopa low protein diet. - Version 8 2026/2027
18. [V8] Loperamide use? - Case 18 PN Pharm 2026/2027
A. Constipation
B. Fever
C. Diarrhea - anti-diarrheal, monitor fluid/electrolytes
D. Pain
Answer: C
Rationale: Loperamide anti-diarrheal. - Version 8 2026/2027
19. [V8] Sertraline interaction? - Case 19 PN Pharm 2026/2027
A. No interactions
B. Safe with MAOI
C. Avoid MAOIs 14 days, risk serotonin syndrome with tramadol/St John's wort
D. No risk
Answer: C
Rationale: SSRI + MAOI serotonin syndrome. - Version 8 2026/2027
20. [V8] LPN cannot do IV push - Case 20 PN Pharm 2026/2027
A. Can do IV push
B. Can do all
C. LPN cannot do IV push meds, initial assessment, teaching, unstable clients
D. Can do assessment
Answer: C
Rationale: LPN scope no IV push, no initial assessment. - Version 8 2026/2027
21. [V8] Insulin lispro onset? - Case 21 PN Pharm 2026/2027
A. 6 hours
B. 15 minutes rapid-acting, peak 1-2h, duration 3-4h
C. 12 hours
D. 2 hours
Answer: B
Rationale: Lispro rapid 15 min onset. - Version 8 2026/2027
22. [V8] Docusate use? - Case 22 PN Pharm 2026/2027
A. Stool softener - softens stool, needs fluids
B. Stimulant
C. Pain
D. Fever
Answer: A
Rationale: Docusate softener. - Version 8 2026/2027
23. [V8] Prednisone long-term side effects? - Case 23 PN Pharm 2026/2027
A. Weight loss
B. Hypoglycemia
C. Weight gain, hyperglycemia, moon face, buffalo hump, osteoporosis, infection risk
D. No effects
Answer: C
Rationale: Steroids cause Cushingoid appearance, hyperglycemia, osteoporosis. - Version 8 2026/2027
24. [V8] Metronidazole teaching? - Case 24 PN Pharm 2026/2027
A. Avoid alcohol during and 48h after - disulfiram reaction nausea/vomiting
B. No teaching
C. Drink alcohol
D. Take with alcohol
Answer: A
Rationale: Flagyl no alcohol disulfiram. - Version 8 2026/2027
25. [V8] Albuterol side effects? - Case 25 PN Pharm 2026/2027
A. Bradycardia
B. Tachycardia, tremor, nervousness - beta2 agonist
C. Weight gain
D. Cough always
, Answer: B
Rationale: Albuterol tachycardia, tremor. - Version 8 2026/2027
26. [V8] Vancomycin infusion reaction red man? - Case 26 PN Pharm 2026/2027
A. Stop forever
B. No action
C. Give fast
D. Infuse slowly over 60-90 min, antihistamine, not allergy
Answer: D
Rationale: Red man from fast infusion - slow infusion. - Version 8 2026/2027
27. [V8] Lisinopril causes dry cough due to? - Case 27 PN Pharm 2026/2027
A. K+ loss
B. Bradykinin accumulation in lungs - ACE inhibitor side effect
C. Na retention
D. Histamine
Answer: B
Rationale: ACE cough from bradykinin. Switch to ARB if intolerable. - Version 8 2026/2027
28. [V8] Hypoglycemia treatment conscious PN? - Case 28 PN Pharm 2026/2027
A. 15g fast carb juice/glucose tabs, recheck 15 min, repeat if <70
B. Water
C. No treatment
D. Give insulin
Answer: A
Rationale: Rule of 15 for hypo. - Version 8 2026/2027
29. [V8] Lithium therapeutic level? - Case 29 PN Pharm 2026/2027
A. 0.1
B. 0.6-1.2 mEq/L, toxicity >1.5 - monitor kidney, thyroid, hydration
C. 10
D. 5.0
Answer: B
Rationale: Lithium narrow therapeutic, monitor. - Version 8 2026/2027
30. [V8] Furosemide expected side effect? - Case 30 PN Pharm 2026/2027
A. Hypokalemia, hypotension, dehydration - monitor K+, I&O;, BP
B. Hyperkalemia
C. No side effects
D. Hypernatremia
Answer: A
Rationale: Loop diuretic wastes K+ - monitor hypokalemia, give K+ rich foods. - Version 8 2026/2027
31. [V8] NPH insulin appearance? - Case 31 PN Pharm 2026/2027
A. No appearance
B. Clear yellow
C. Clear
D. Cloudy - must roll not shake, 30 min to 1h onset, peak 4-12h
Answer: D
Rationale: NPH cloudy intermediate. - Version 8 2026/2027
32. [V8] Haloperidol EPS treatment? - Case 32 PN Pharm 2026/2027
A. No monitor
B. Benztropine/diphenhydramine for acute dystonia, monitor EPS
C. Stop water
D. No treatment
Answer: B
Rationale: Antipsychotic EPS benztropine. - Version 8 2026/2027
33. [V8] Bisacodyl use? - Case 33 PN Pharm 2026/2027
A. Diarrhea
B. Fever
C. Constipation - stimulant laxative
D. Pain
Answer: C
Rationale: Stimulant laxative. - Version 8 2026/2027
34. [V8] Acetaminophen overdose antidote? - Case 34 PN Pharm 2026/2027
A. Naloxone
